These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18034763)

  • 1. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes.
    Kearon C
    J Thromb Haemost; 2007 Dec; 5(12):2330-5. PubMed ID: 18034763
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
    Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F
    Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.
    Kearon C; Akl EA
    Blood; 2014 Mar; 123(12):1794-801. PubMed ID: 24497538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach.
    Black SA; Cohen AT
    Thromb Haemost; 2015 Oct; 114(4):660-9. PubMed ID: 26084864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprovoked deep vein thrombosis should be treated with long-term anticoagulation--no.
    Baglin T
    J Thromb Haemost; 2007 Dec; 5(12):2336-9. PubMed ID: 17892533
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct oral anticoagulants and venous thromboembolism.
    Franchini M; Mannucci PM
    Eur Respir Rev; 2016 Sep; 25(141):295-302. PubMed ID: 27581829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of anticoagulation: the decision-making process.
    Thompson R; Thachil J
    Br J Hosp Med (Lond); 2015 Oct; 76(10):C156-60. PubMed ID: 26457953
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants.
    Rosovsky R; Merli G
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):141-151. PubMed ID: 29029708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulodexide for the extended treatment of venous thromboembolism.
    Walenga JM; Fareed J; Ramacciotti E
    Int Angiol; 2016 Dec; 35(6):531-533. PubMed ID: 27680735
    [No Abstract]   [Full Text] [Related]  

  • 11. Extended anticoagulation after venous thromboembolism: should it be done?
    Fernandes CJ; Calderaro D; Piloto B; Hoette S; Jardim CVP; Souza R
    Ther Adv Respir Dis; 2019; 13():1753466619878556. PubMed ID: 31558116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprovoked Venous Thromboembolism: The Search for the Cause.
    Mwansa H; Zghouzi M; Barnes GD
    Med Clin North Am; 2023 Sep; 107(5):861-882. PubMed ID: 37541713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of cancer-associated venous thromboembolism - a case-based practical approach.
    Voigtlaender M; Langer F
    Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.
    Khorana AA; Noble S; Lee AYY; Soff G; Meyer G; O'Connell C; Carrier M
    J Thromb Haemost; 2018 Sep; 16(9):1891-1894. PubMed ID: 30027649
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.
    Baglin T; Bauer K; Douketis J; Buller H; Srivastava A; Johnson G;
    J Thromb Haemost; 2012 Apr; 10(4):698-702. PubMed ID: 22332937
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism.
    Bauer KA
    JAMA; 2011 Apr; 305(13):1336-45. PubMed ID: 21386068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
    Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
    Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on extended treatment for venous thromboembolism.
    Peñaloza-Martínez E; Demelo-Rodríguez P; Proietti M; Soria Fernández-Llamazares G; Llamazares-Mendo C; Álvarez-Sala Walther L; Marra AM; Del Toro-Cervera J
    Ann Med; 2018 Dec; 50(8):666-674. PubMed ID: 30345825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.